06826.HK
Shanghai Haohai Biological Technology Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 15.20
−5.65%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 6.47x
- P/E 2027E
- 5.83x
- P/E 2028E
- 5.43x
- P/S forward
- 2.02x
Trailing multiples
Trailing twelve months
- P/E TTM
- 20.63x
- PEG TTM
- 16.31x
- Price / book
- 0.55x
- Price / sales
- 1.26x
- Price / cash flow
- 5.88x
Enterprise value
- Enterprise value
- HKD 1.3B
- EV / sales
- 0.49x
- EV / EBITDA
- 5.94x
- EV / EBIT
- -29.77x
- Market cap
- HKD 3.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026